Author: WTN News

The Madison-based biopharmaceutical firm Centrose continues to make progress toward developing therapies for cancer. The company has announced that two of its lead drug candidates have demonstrated, in animal models, the ability to kill cancer cells in colorectal and non-small lung cancers. Centrose, which will...

As your technology business heads toward an initial public offering or a merger, the task of financial planning with stock options starts with leveraging the value of those options to the highest level, according to columnist and attorney Sverre Roang. In this WTN Guest Column,...

Spurred on by the 2007 acquisition of Madison's NimbleGen by the pharma giant Roche, Wisconsin officials and biotech companies are on the hunt for additional collaborations with large pharmaceutical firms. The 2008 BIO Convention in San Diego this month will provide the perfect opportunity for...

In what is being described as a powerful technology combination, Madison's Gentel Biosciences will team with Germany's Eppendorf AG under a license-and-supply agreement designed to advance protein array applications. With the deal, Gentel adds to its intellectual property footprint and gains access to new markets...

Hard-to-search wave files make e-discovery compliance a challenging proposition for organizations that have made the switch from traditional voice service to a unified communications platform. Unfortunately, the potential solution - voice recognition technology - is improving but not completely ready for prime time, leaving the...

The global medical device industry is even more robust than big pharma but there is a real synergy developing between the two that is important to the Midwestern states that boast of a strong medical device industry, notes columnist Michael Rosen. In this edition of...

Wisconsin's entrepreneurial climate is strengthened by individual quality and by an increasing number of new start-ups, according to columnist Tom Still. In this edition of Inside Wisconsin, Still touts encouraging entrepreneurial news from the likes of the Ewing Marion Kauffman Foundation, but he writes that...

Two Wisconsin companies will present to a gathering of 20,000 industry representatives and investors at the forthcoming 2008 BIO International Convention in San Diego. Invivosciences of Milwaukee and Primorigen Biosciences of McFarland will make formal presentations about their companies during the four-day event, which begins...